When was Oterus Biosystems founded?

Oterus Biosystems was founded in 2024.

Where is Oterus Biosystems located?

Oterus Biosystems is headquartered in United States.

Where does Oterus Biosystems rank among its competitors?

Oterus Biosystems ranks 51st amongst 55 active competitors, of which 11 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was AutoIVF, which secured $2.92M in Sep, 2025.

Who are the top competitors of Oterus Biosystems?

Oterus Biosystems' top competitors include INVO Bioscience, AutoIVF and The Well Bioscience. Among them, AutoIVF secured the most recent funding round in September, 2025.

Oterus Biosystems - 2026 Company Profile & Competitors

Company Details

Developer of biomimetic substrate technology for in vitro embryo culture. The technology provides a scaffold that mirrors the biochemical and structural cues of the uterine lining to improve embryo development. By replacing standard culture surfaces with biocompatible polymers, the substrate offers a microenvironment designed to optimize embryo competency. This approach addresses the limitations of traditional culture conditions by recreating natural biological cues during the early stages of development. The material is intended to enhance outcomes in laboratory settings through precise nanoscale surface architecture.

Key Metrics

Founded Year

2024

Location

United States

Stage

Unfunded

Ranked

51^st among 55 active competitors

Similar Companies

INVO Bioscience & 61 more

View Oterus Biosystems' full profile

Oterus Biosystems has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Oterus Biosystems include INVO Bioscience, AutoIVF and The Well Bioscience. Here is the list of Top 10 competitors of Oterus Biosystems, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	INVO Bioscience 2007, Medford (United States), Public	A medical device company specializing in fertility solutions	-	FOD Capital	53/100
2nd	AutoIVF 2018, Natick (United States), Seed	Developer of solutions to automate and improve In Vitro Fertilization procedures	$5M	Vitrolifegroup, Alpha Edison & 2 others	51/100
3rd	The Well Bioscience 2015, Newark (United States), Unfunded	Xeno-free hydrogels and bioinks for 3D cell culture and bioprinting	-	-	43/100
4th	Béa Fertility 2020, London (United Kingdom), Series A	Provider of a device for fertility treatment	$4.31M	Pioneer Group, Calm/Storm & 23 others	40/100
5th	FertiliTech 2003, Aarhus (Denmark), Acqui-Hired	Develops a technology that improves embryo selection in IVF clinics	$44M	-	38/100
6th	Mo:re 2023, Hamburg (Germany), Seed	Developer of 3D cell culture robot for medical research	$2.48M	HTGF, RandR Medical & 5 others	35/100
7th	Mosie Baby 2014, Austin (United States), Series A	Artificial insemination solution for women	$1.08M	37 Angels, Magic Fund & 5 others	35/100
8th	Entropic Biosciences 2023, Los Angeles (United States), Unfunded	Developer of 3D multicellular organoid systems	-	-	33/100
9th	Celloid 2021, Pohang si (South Korea), Seed	Provider of 3D cell culture solutions for drug development	$1.8M	POSTECH Holdings, FuturePlay	30/100
10th	Kangaroo Biomedical 2023, San Francisco (United States), Funding Raised	Platform offering artificial reproductive procedures	-	VU Venture Partners	30/100
51st	Oterus Biosystems 2024, United States, Unfunded	Developer of biomimetic substrate technology for in vitro embryo culture	-	-	16/100